Clover Health Investments Corp

CLOV.US
Healthcare · Healthcare Plans
4.34
+0.07 (+1.52%)
USD · NASDAQ

Company Information

Company Name
Clover Health Investments Corp
Sector
Healthcare
Industry
Healthcare Plans
Exchange
NASDAQ
ISIN: US18914F1030
CIK: 0001144514
CUSIP: 18913V109
Currency: USD
Full Time Employees: 724
Phone: 201 432 2133
Fiscal Year End: December
IPO Date: Jan 02, 2001
Description:

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.

Address:

1209 Orange Street, Wilmington, DE, United States, 19801

People

Directors & Officers

Name Title Year Born
Mr. Vivek Garipalli Co-Founder & Executive Chairman 1979
Mr. Andrew Toy Co-Founder, CEO & Director 1979
Ms. Jamie L. Reynoso Chief Executive Officer of Medicare Advantage 1969
Mr. Conrad Wai CEO of Counterpart Health 1981
Mr. Clay Thornton Interim Chief Financial Officer 1990
Mr. Joseph Frank Oldakowski VP of Finance, Controller & Principal Accounting Officer 1983
Ms. Wendy Richey Chief Compliance Officer NA
Ms. Karen Soares Chief Legal Officer, General Counsel, Senior VP & Corporate Secretary 1978
Ms. Rachel Fish Chief People Officer NA
Dr. Kumar Dharmarajan Chief Medical Officer of Clover Assistant 1980

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 04, 2026 Brady Patrick Priest N/A Sale 175.00K $2.17 $379.75K
Aug 13, 2025 Anna U Loengard N/A Purchase 26.50K $2.59 $68.64K
Jul 23, 2025 Conrad Wai N/A Sale 91.20K $3.32 $302.77K
Jul 22, 2025 Conrad Wai N/A Sale 118.60K $3.29 $390.19K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 31.84M Mar 31, 2026 6.05% $0.00 -1.36%
Vanguard Group Inc 23.49M Dec 31, 2025 4.46% $0.00 1.85%
Vanguard Capital Management, LLC 16.98M Mar 31, 2026 3.22% $0.00 0.00%
Geode Capital Management, LLC 10.06M Mar 31, 2026 1.91% $0.00 2.70%
State Street Corp 9.56M Mar 31, 2026 1.82% $0.00 2.57%
Charles Schwab Investment Management Inc 5.30M Mar 31, 2026 1.01% $0.00 12.99%
PNC Financial Services Group Inc 3.76M Mar 31, 2026 0.71% $0.00 0.00%
Vanguard Portfolio Management, LLC 3.70M Mar 31, 2026 0.70% $0.00 0.00%
Dimensional Fund Advisors, Inc. 3.42M Mar 31, 2026 0.65% $0.00 -5.96%
Renaissance Technologies Corp 3.40M Mar 31, 2026 0.65% $0.01 -24.26%
Northern Trust Corp 3.31M Mar 31, 2026 0.63% $0.00 4.03%
Vanguard Fiduciary Trust Co 2.81M Mar 31, 2026 0.53% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 2.19M Mar 31, 2026 0.42% $0.00 -15.88%
The Goldman Sachs Group Inc 2.17M Mar 31, 2026 0.41% $0.00 21.58%
Citadel Advisors Llc 1.88M Mar 31, 2026 0.36% $0.00 63.60%
UBS Group AG 1.77M Mar 31, 2026 0.34% $0.00 34.40%
HRT FINANCIAL LLC 1.67M Mar 31, 2026 0.32% $0.01 0.00%
GMT Capital Corp 1.31M Mar 31, 2026 0.25% $0.10 0.00%
Millennium Management LLC 1.16M Mar 31, 2026 0.22% $0.00 0.00%
Bank of New York Mellon Corp 1.14M Mar 31, 2026 0.22% $0.00 -2.95%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 12.98M 2.47% ▲ 2.87% Jun 30, 2026
2 iShares Russell 2000 ETF 10.86M 2.06% ▲ 0.60% Jun 30, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 4.65M 0.88% ▲ 2.87% Jun 30, 2026
4 Fidelity Small Cap Index 4.04M 0.77% ▲ 0.85% Apr 30, 2026
5 iShares Russell 2000 Growth ETF 3.87M 0.73% ▼ 0.38% Jun 30, 2026
6 Russell 2000 Index Non-Lendable Fund 2.79M 0.53% ▲ 7.94% Jun 30, 2026
7 Russell 2000 Equity Index Fund B 2.79M 0.53% ▲ 7.94% Jun 30, 2026
8 Vanguard Russell 2000 ETF 2.42M 0.46% ▲ 15.16% Jun 30, 2026
9 State St Russell Sm/Mid Cp® Indx SL Cl I 2.40M 0.46% ▲ 0.00% Jun 30, 2026
10 Fidelity Extended Market Index 2.07M 0.39% ▼ 3.90% May 31, 2026

Financial Highlights

Market Cap: $2.28B
EBITDA: $-56.69M
Book Value: $0.65
Earnings/Share: $-0.12
Profit Margin: -2.58%
Operating Margin: 3.65%
ROA (TTM): -5.55%
ROE (TTM): -16.86%
Revenue (TTM): $2.21B
Revenue/Share (TTM): $4.27
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 62.00%

Valuation Metrics

Enterprise Value: $1.92B
Trailing P/E: 0.00
Forward P/E: 81.97

Shares Statistics

Shares Outstanding: 430.97M
Shares Float: 408.51M
% Insiders: 430.50%
% Institutions: 3,004.90%
Short % Float: 6.92%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.92B
Cost of Goods Sold
adjust
$-1.57B
Gross Profit
subtotal
$355.88M
SG&A
adjust
$-176.32M
Other Operating Expense
adjust
$-265.11M
Operating Income
subtotal
$-85.53M
Other / Non-Operating Items
adjust
$-20.00K
Net Income
subtotal
$-85.55M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about CLOV.US!